chevron_leftBack
As of 5 June 2026, Cenra Inc. has a market cap of $150.52M USD, ranking #22858 globally and #1131 in Taiwan.
It ranks #2054 in the Healthcare sector, and #741 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$150.52MUSD
4.73B TWD
Enterprise Value
$223.53MUSD
7.03B TWD
Revenue (TTM)
$272.44MUSD
8.57B TWD
EBITDA (TTM)
$22.87MUSD
719.5M TWD
Net Income (TTM)
$9.54MUSD
300.07M TWD
EBITDA Margin
8.4%
Profit Margin
3.5%
PE Ratio
13.6
PS Ratio
0.6
PB Ratio
0.6
EV/EBITDA
9.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Hou-Kai Wang
open_in_new
Employees
542
Founded
1952
Website
cenra.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 1.6% | 0.6% | -1.8% | -4.8% | -4% | -7.3% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
3716
中化投資控股股份有限公司
ISIN: TW0003716007
Shares Out.:
Shares Outstanding:
146.141M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
32.40 TWD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Cenra Inc.
Cenra Inc. engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals. It offers active pharmaceutical ingredients, generic drugs for human use, over to the counter drugs, self-care products for the prevention of diseases, home care and cosmetics, and animal healthcare products. The company is also involved in the research and development, contracting manufacturing and international, and senior care services, as well as distributes and sells pharmaceutical brands. In addition, it offers containers and plastic products. Cenra Inc. was founded in 1952 and is headquartered in Taipei, Taiwan.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TWSE: 6446
|
$7.8B
5K%
245.34B TWD
|
48.6
|
|
TWSE: 1795
|
$1.84B
1K%
57.95B TWD
|
12.2
|
|
TPEX: 4123
|
$925.55M
515%
29.11B TWD
|
3.4
|
|
TPEX: 6535
|
$809.3M
438%
25.46B TWD
|
-
|
|
TPEX: 4743
|
$789.12M
424%
24.82B TWD
|
-
|
|
TPEX: 4105
|
$584.14M
288%
18.38B TWD
|
11.8
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
506K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
363K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
239K%
|
97.4
|
|
SIX: RO
|
$324.68B
216K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.43B
192K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$277.35B
184K%
218.9B CHF
|
20.5
|
chevron_leftBack